3 Results for "

SARS-CoV-2-IN-11

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "SARS-CoV-2-IN-11" in MCE Product Catalog:

Cat. No.: HY-145277
CAS No.: 2722635-28-9
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-11 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.17 and 1.45 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals .
loading...
    loading...
Cat. No.: HY-174320
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-112 (Compound 6f) is an orally active and non-peptidic SARS-CoV-2 main protease inhibitor with an IC50 of 6.48 μM. SARS-CoV-2-IN-11 has potent antiviral activity with low cytotoxicity against WI-38 cells (IC50: 53.81 μM). SARS-CoV-2-IN-112 can be used for coronaviruses COVID-19 research .
loading...
    loading...
Cat. No.: HY-145276
CAS No.: 2722634-95-7
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2-IN-10 is a potent and nontoxic inhibitor of SARS-CoV-2 3CL protease (3CLpro) with an IC50 and EC50 of 0.13 and 1.03 nM, respectively. SARS-CoV-2 3C-like protease (3CLpro), an enzyme essential for viral replication, is an attractive target for intervention. SARS-CoV-2-IN-11 may lead to the emergence of effective SARS-CoV-2-specific antivirals .
loading...
    loading...